Overview Executive Committee Supervisory Board Locations
Overview

Satraplatin

Kinase Inhibitors
Stock Key Figures Financial Reports SEC Filings Corporate Governance Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Satraplatin Clinical Trials

Strategic Alliances

Print preview

Print

Anticancer Programs


Satraplatin

 

Satraplatin is not currently approved by the FDA in the United States, by the EMEA in the European Union or any other regulatory authority and no conclusions can or should be drawn regarding its safety and efficacy.

 

 

Anticancer Programs | Satraplatin